Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 9, 2010, Pages 2001-2010

  Lin, C C ^a,b   Ezzelarab, M ^a   Hara, H ^a   Long, C ^a   Lin, C W ^a   Dorling, A ^c   Cooper, D K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Atorvastatin; Coagulation; Tissue factor; Tissue factor pathway inhibitor; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANTIGEN; ATORVASTATIN; IMMUNOGLOBULIN G; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; ANTICOAGULATION; ANTIGEN BINDING; AORTA; ARTICLE; BABOON; CELL ACTIVATION; CONTROLLED STUDY; DNA MODIFICATION; ENDOTHELIUM CELL; KNOCKOUT GENE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; TRANSGENICS; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, ANTI-IDIOTYPIC; ANTICHOLESTEREMIC AGENTS; ANTICOAGULANTS; ANTIGENS, CD46; AORTA; BLOOD COAGULATION; ENDOTHELIUM, VASCULAR; GALACTOSYLTRANSFERASES; HEPTANOIC ACIDS; LIPOPROTEINS; PAPIO; PYRROLES; SWINE; TRANSGENES;

EID: 77956469984     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03950.x     Document Type: Article

References (23)

1. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002, 53:133-47.
2. Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, Lancos CJ, Prabharasuth DD, Cheng J, Moran K, Hisashi Y, Mueller N, Yamada K, Greenstein JL, Hawley RJ, Patience C, Awwad M, Fishman JA, Robson SC, Schuurman HJ. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005, 11:29-31.
3. Nagayasu T, Saadi S, Holzknecht RA, Plummer TB, Platt JL. Expression of tissue factor mRNA in cardiac xenografts: clues to the pathogenesis of acute vascular rejection. Transplantation 2000, 69:475-82.
4. Gollackner B, Goh SK, Qawi I, Buhler L, Knosalla C, Daniel S, Kaczmarek E, Awwad M, Cooper DK, Robson SC. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 2004, 77:1735-41.
5. Lin CC, Chen D, McVey JH, Cooper DK, Dorling A. Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells. Transplantation 2008, 86:702-9.
6. Chen G, Qian H, Starzl T, Sun H, Garcia B, Wang X, Wise Y, Liu Y, Xiang Y, Copeman L, Liu W, Jevnikar A, Wall W, Cooper DK, Murase N, Dai Y, Wang W, Xiong Y, White DJ, Zhong R. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005, 11:1295-8.
7. Chen D, Riesbeck K, McVey JH, Kemball-Cook G, Tuddenham EG, Lechler RI, Dorling A. Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins. Transplantation 1999, 68:832-9.
8. LaRosa JC. Pleiotropic effects of statins and their clinical significance. Am J Cardiol 2001, 88:291-3. S0002-9149(01)01643-5
9. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SB, Lamborn AE, Garst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003, 299:411-4.
10. Loveland BE, Johnstone RW, Russell SM, Thorley BR, McKenzie IF. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis. Transpl Immunol 1993, 1:101-8.
11. Riesbeck K, Dorling A, Kemball-Cook G, McVey JH, Jones M, Tuddenham EG, Lechler RI. Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface. Thromb Haemost 1997, 78:1488-94.
12. Chen D, Weber M, McVey JH, Kemball-Cook G, Tuddenham EG, Lechler RI, Dorling A. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am J Transplant 2004, 4:1958-63.
13. Ayares D, Phelps CJ, Vaught TD, Ball S. Genetic engineering of pigs for improved transplant outcomes. Xenotransplantation 2007, 14:428.
14. Hara H, Long C, Lin YJ, Tai HC, Ezzelarab M, Ayares D, Cooper DK. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 2008, 21:1163-74.
15. Eto M, Kozai T, Cosentino F, Joch H, Luscher TF. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 2002, 105:1756-9.
16. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007, 7:519-31.
17. Saethre M, Baumann BC, Fung M, Seebach JD, Mollnes TE. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Transplantation 2007, 84:244-50.
18. Kelishadi SS, Zhang T, Stoddard T, Azimzadeh AM, Welty E, Avon CJ, Larris A, Cheng XF, Barth R, Pierson RN. Addition of HDAF to the Gal -KO background improved survival and function of pig kidneys in baboons. Am J Transplant 2008, 8:205.
19. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001, 103:276-83.
20. Davidson MH, Stein EA, Dujovne CA, Hunninghake DB, Weiss SR, Knopp RH, Illingworth DR, Mitchel YB, Melino MR, Zupkis RV, Dobrinska MR, Amin RD, Tobert JA. The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol 1997, 79:38-42.
21. Ferrara DE, Swerlick R, Casper K, Meroni PL, Vega-Ostertag ME, Harris EN, Pierangeli SS. Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 2004, 2:1558-63.
22. Ezzelarab M, Welchons D, Torres C, Hara H, Long C, Yeh P, Ayares D, Cooper DK. Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro. Transplantation 2008, 86:733-7.
23. Lin CC, Cooper DK, Dorling A. Coagulation dysregulation as a barrier to xenotransplantation in the primate. Transpl Immunol 2009, 21:75-80.